Table 3. Myocardial protection strategies for included studies.
| Study | Cardioplegia strategy | CPB temperature (°C) | Patent CABG grafts occluded |
|---|---|---|---|
| Byrne | Retrograde, after initial antegrade dose | 20-25 | No |
| Grossi | Retrograde | NR | NR |
| Svensson | Antegrade + retrograde | 22 | No |
| Mihaljevic | Antegrade or retrograde | 20-22 | No |
| Sharony | Antegrade + retrograde | 25-28 | NR |
| Bakir | Antegrade + retrograde | 26.2±4 | NR |
| Totaro | Antegrade | NR | No |
| Gaeta | Antegrade +/or retrograde | 24-33 | Yes |
| Pineda | Retrograde, after initial antegrade dose | 28 | No |
| Mikus | Antegrade | Normothermia | No |
| Kaneko | Antegrade + retrograde | 28-32 (without patent LITA) 20-30 (with patent LITA) |
No |
CPB, cardiopulmonary bypass; NR, not reported; +, indicates combined strategy; LITA, left internal thoracic artery; CABG, coronary artery bypass graft.